13F Pro Quality Score

63.4/100

Rank #689 of 2,879 stocksTOP 25%

View Consumer Staples peers →

Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.

Revenue Growth

50.9/100

Profitability

72.0/100

Balance Sheet

89.3/100

Earnings Quality

38.7/100

Free Cash Flow

44.4/100

Institutional Flow

77.9/100

Revenue Scale

56.7/100

Dilution Risk

88.2/100

IPAR Stock Analysis & AI Quality Score

AI stock analysis and institutional research for INTERPARFUMS INC (IPAR), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores IPAR at 63.4/100 on a 32-signal composite quality model, placing it at rank #689 of 2,879 stocks — the top 25% of the AI-ranked universe. IPAR scores in the top quartile across balance sheet strength (89.3), institutional flow (77.9). Areas of concern include earnings quality (38.7), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), INTERPARFUMS INC reports quarterly revenue of $344.9M, net income of $43.4M, an operating margin of 21.5%. Top institutional holders of IPAR by reported 13-F value include BlackRock,, MORGAN STANLEY, VANGUARD PORTFOLIO MANAGEMENT, based on the most recent SEC filings. IPAR trades on the Nasdaq exchange and files with the SEC under CIK 822663. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate IPAR daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for INTERPARFUMS INC directly from SEC EDGAR. INTERPARFUMS INC's 13F Pro composite quality score has ranged between 8 and 76 since 2024, currently 63.4 — a declining long-term trajectory across 41 quarterly and live scoring snapshots.

Fun facts about INTERPARFUMS INC

Quirks, history, and lore behind IPAR — the kind of stuff that makes a stock memorable.

  • 1
    The Basics
    U.S. consumer staples company · small-cap · listed on Nasdaq · headquartered in New York City.
  • 2
    The Numbers
    Annual revenue in the range of $500–600 million — modest by S&P standards, yet it commands premium pricing in a notoriously fickle industry where margins actually hold up.
  • 3
    The History
    Founded in the late 1980s, it built its business not by making fragrances itself but by licensing the names of fashion designers and celebrities and slapping them on bottles.
  • 4
    The Secret
    It's essentially a brand-licensing machine — the real asset isn't a factory or a formula, it's the right to put someone else's famous name on a perfume box.
  • 5
    The Lore
    Its portfolio includes licensed scents for names like Jimmy Choo, Montblanc, and Donna Karan — proving you don't have to own a fashion house to profit from one.
  • 6
    The Giveaway
    If you've ever spritzed a designer fragrance at a department store counter, there's a solid chance this New York perfume licensor — ticker IPAR — quietly made it.
▶ Think you know your stocks? Play the Daily Ticker

Revenue

Q1 2026

$344.9M

Net Income

Q1 2026

$43.4M

Free Cash Flow

Q1 2026

$-1.3M

Operating Margin

Q1 2026

21.5%

D/E Ratio

Q1 2026

0.18

Revenue & Net Income

Earnings Per Share

Key Financials Over Time

Export Financial Table · Pro+

Revenue

+2.5% YoY
$1.49BFY 2025
FY20 $539.0MFY21 $879.5MFY24 $1.45BFY25 $1.49B

Net Income

+2.5% YoY
$168.4MFY 2025
FY20 $38.2MFY21 $87.4MFY24 $164.4MFY25 $168.4M

Operating Income

-1.6% YoY
$270.3MFY 2025
FY20 $70.1MFY21 $148.1MFY24 $274.8MFY25 $270.3M

EPS (Diluted)

+2.3% YoY
$5.24FY 2025
FY20 $0.00FY21 $2.75FY24 $5.12FY25 $5.24

Total Assets

+12.3% YoY
$1.59BFY 2025
FY20 $890.1MFY21 $1.15BFY24 $1.41BFY25 $1.59B

Total Debt

+15.9% YoY
$240.2MFY 2025
FY20 $39.3MFY21 $164.7MFY24 $207.2MFY25 $240.2M

Op. Cash Flow

+14.5% YoY
$214.9MFY 2025
FY20 $65.0MFY21 $119.6MFY24 $187.6MFY25 $214.9M

AI Insight: IPAR Financial Trends

IPAR shows steady revenue and earnings stability year-over-year, but total debt has risen 14% from Q1 2025 to Q1 2026 while operating income compressed sharply in Q4 2025.

Revenue is broadly flat year-over-year: Q1 2026 at $345M versus Q1 2025 at $339M, and Q3 2025 at $430M matching Q3 2024's $425M.

Q4 2025 operating income collapsed to $28M from $36M in Q4 2024, despite revenue growing from $362M to $386M — a sharp margin deterioration.

Total debt rose from $151M in Q1 2025 to $240M in Q4 2025 before declining to $157M in Q1 2026, while equity steadily grew from $789M to $882M.

Net income held resilient in seasonal peaks: Q3 2025 net income of $66M exceeded Q3 2024's $62M, suggesting modest earnings growth in core quarters.

Q4 2025 operating income of $28M on $386M revenue implies a ~7% op margin, well below Q4 2024's ~10% — a meaningful margin compression to monitor.

Operating cash flow turned negative in Q1 2025 at -$7M and nearly zero in Q1 2026 at $0M — watch whether this seasonal pattern worsens.

Total debt has trended structurally higher, reaching $240M in Q4 2025 versus $207M a year prior; debt-to-equity remains manageable but is expanding.

AI Insight: IPAR Ratio Trends

IPAR's profitability remains intact but ROIC has structurally compressed year-over-year across every comparable quarter.

ROIC in Q1 2026 fell to 28.5% from 32.0% in Q1 2025, continuing a pattern of year-over-year ROIC erosion in matching quarters.

Q4 seasonality is severe: OpMargin collapsed to 7.1% in Q4 2025 vs. 25.3% in Q3 2025, mirroring the Q4 2024 drop to 10.0%.

Operating margin in Q1 2026 held at 21.5%, roughly in line with Q1 2025's 22.2%, suggesting stable underlying cost structure.

D/E ratio improved to 0.18 in Q1 2026, the lowest reading in the dataset, signaling a strengthening balance sheet.

ROIC peaked at 44.3% in Q3 2024 and has since trended lower to 40.7% in Q3 2025 — peak returns may be behind us.

Q4 OpMargin deteriorated further to 7.1% in Q4 2025 from 10.0% in Q4 2024 — watch whether Q4 weakness is deepening.

TTM ROIC of 25.9% sits well below any single peak quarter, reflecting how seasonal troughs drag full-year capital efficiency.

Get alerted when IPAR's score changes

Free account: watchlist tracking, the daily AI brief, and the AI screener.

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Available Research

13F Pro tracks comprehensive data for INTERPARFUMS INC including:

SEC EDGAR filings (10-K, 10-Q, 8-K)
XBRL financial facts (revenue, EPS, margins)
Insider transactions (Form 4)
Institutional 13F holdings
Quality rankings (32 signals)
AI analyst debates & daily meetings
Historical financial trends
Peer comparison & sector analysis

Top Institutional Holders of IPAR

Put IPAR on your watchlist

Track score changes the day INTERPARFUMS INC files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.

View Pricing

Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).

Passwordless sign-in · Payments by Stripe · Auth by Clerk

Is IPAR a good stock to buy?

13F Pro's AI-powered analysis of INTERPARFUMS INC (IPAR) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for IPAR are available on the IPAR stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.

Which hedge funds own IPAR?

Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling IPAR. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of INTERPARFUMS INC's investment landscape.